Artificial disc replacement technology has made significant growth in 2023. Here are seven key developments to know:
Spinal Tech
Here are 10 spine devices earning FDA approvals and clearances since Oct. 1.
John Booth is retiring from his role as CEO and director of Spineology, a minimally invasive surgery technology company.
Thousands of prospective patients have shown interest in Neuralink, and the company overseen by Elon Musk has ambitious plans for upcoming human trials, Bloomberg reported Nov. 6.
Stryker, Johnson & Johnson and Zimmer Biomet posted their third quarter financial results for 2023, and data on their orthopedic sales.
Advertisement
Globus Medical reported $383.6 million in global net sales during the third quarter, according to a Nov. 7 news release.
Spine medtech company Alphatec recently reported $118 million in total revenue for the third quarter of 2023.
Orthofix's WaveForm L interbody sytem is out in a full commercial release, the company said Nov. 6.
Stryker on Nov. 2 posted $4.9 billion in third quarter net sales.
Centinel Spine, a global medical device company and the creator of the Prodisc total disc replacement product line, has exceeded $17 million in revenue in the third quarter of the year, its highest grossing quarter to date.